Chemotherapy of first line "reinforced" for cancers of the colonist and the rectum with hepatic and/or pulmonary metastases potentially resecables: Strong association FOLFIRI and ERBITUX.
Phase of Trial: Phase II
Latest Information Update: 13 Jun 2013
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Cancer metastases; Colorectal cancer
- Focus Therapeutic Use
- Acronyms ERBIFORT
- 06 Nov 2012 Planned End Date (8 Jul 2012) added as reported by European Clinical Trials Database record.
- 07 Aug 2012 Additional lead trial centre added as reported by European Clinical Trials Database record.
- 04 Jul 2012 Merck KGaA and Pfizer added as associations as reported in the European Clinical Trials Database record.